Quest Diagnostics Updates FY23 Adj EPS Outlook From $.50 - $8.90 To $8.65 - $8.75 Vs. $8.71 Est.
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics has updated its FY23 adjusted EPS outlook from a range of $.50 - $8.90 to a narrower range of $8.65 - $8.75, which is in line with the estimated $8.71.
October 24, 2023 | 10:54 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Quest Diagnostics' updated FY23 adjusted EPS outlook is in line with estimates, which may stabilize the stock price.
Quest Diagnostics' updated FY23 adjusted EPS outlook is in line with the estimated $8.71. This alignment with estimates may prevent any drastic changes in the stock price, as it indicates that the company's performance is as expected by the market.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100